Abstract 105P
Background
Cell-free methylated DNA immunoprecipitation sequencing (cfMeDIP-Seq) is a promising approach to assess non-invasive methylomics. Despite its cost-efficiency and accuracy, the setup and processing of cfMeDIP-Seq are technically challenging. The original protocol developed by Shen et al. in 2019 can now be partially automated, potentially improving reproducibility and yield.
Methods
We designed a pilot study to evaluate the performance of cfMeDIP-Seq under 4 library preparation conditions. We collected 4 K2EDTA and 4 PAXgene ccfDNA tubes (BD Vacutainer™) from the same healthy donor. We processed K2EDTA and PAXgene tubes within 2 and 6 hours of blood draw respectively, as previously described (Dameri et al., 2023). We used 10 ng of cfDNA for library preparation. Each condition underwent 2 parallel preparation procedures: one following the manual protocol described by Shen et al., and the other following a semi-automated version of the original protocol using the IP-Star® Compact instrument (Diagenode). We generated a total of 16 libraries, 4 for each condition, and sequenced them on Illumina NovaSeq 6000 device.
Results
The number of uniquely mapped reads was comparable (p-value = 0.8) between semi-automated and manually processed libraries, with an average of 19.9 MReads per sample. The percentage of duplicates was reduced (p-value = 0.0012) in semi-automated libraries (median = 32.88; IQR = 31.94-34.06) compared to manually prepared ones (median = 41.48; IQR = 35.61-42.53). Semi-automated libraries showed a longer mean insert size (255 bp) compared to manually processed libraries (243 bp) with a p-value < 0.01. Principal component analysis revealed no major differences between K2EDTA and PAXgene samples processed with the semi-automated protocol. We observed no significant differences across the 4 conditions in terms of GC content (47%, sd = 0.49).
Conclusions
In the present pilot study, we demonstrated that semi-automated library preparation outperformed the fully manual protocol, regardless of tube type but provided that K2EDTA were processed shortly after collection. Partial automation of fluidic handling seems extremely relevant to increase yield and quality of cfMeDIP-Seq experiments.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
The authors.
Funding
Associazione Italiana per la Ricerca sul Cancro (AIRC) and 5x1000 by Italian Ministry of Health.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
30P - Role of microRNA and CDKN2A/p16INK4a expression in the prognostication of oral squamous cell carcinoma
Presenter: Olha Burtyn
Session: Cocktail & Poster Display session
Resources:
Abstract
31P - Identification of proteins associated with mRNA processing and maturation by quantitative proteomic analysis in Indian cervical cancer patients
Presenter: Amrita Mukherjee
Session: Cocktail & Poster Display session
Resources:
Abstract
32P - Expression of STAT3 and hypoxia markers in repeatedly resected glioma patients
Presenter: Katerina Dvorakova
Session: Cocktail & Poster Display session
Resources:
Abstract
33P - Unraveling the mechanisms of cisplatin resistance in bladder organoid by single cell RNA sequencing
Presenter: Tingting Xie
Session: Cocktail & Poster Display session
Resources:
Abstract
34P - Functional diagnostics and ex-vivo screening of erlotinib and nintedanib in non-small cell lung carcinoma: Implications for multidrug resistance and personalized therapy
Presenter: Jelena Dinić
Session: Cocktail & Poster Display session
Resources:
Abstract
35P - Enhancing efficacy of the MEK inhibitor trametinib in KRAS-mutated colorectal cancer cells
Presenter: Lee Ellis
Session: Cocktail & Poster Display session
Resources:
Abstract
36P - Comparison of pelitinib, tepotinib or docetaxel efficacy according to the copy number or gene alteration status of EGFR, MET, HRAS, KRAS and NRAS genes
Presenter: Dae Young Zang
Session: Cocktail & Poster Display session
Resources:
Abstract
37P - NET-mediated radio-resistance in early-stage non-small cell lung cancer
Presenter: Malcolm Ryan
Session: Cocktail & Poster Display session
Resources:
Abstract
39P - The use of antibiotics or proton pump inhibitors and the response to intravesical Bacillus Calmette Guérin therapy in non-muscle-invasive bladder cancer
Presenter: João Barbosa Martins
Session: Cocktail & Poster Display session
Resources:
Abstract
40P - YAP1 promotes sorafenib resistance by activation of TGFβ signaling pathway
Presenter: Chit Lai Chee
Session: Cocktail & Poster Display session
Resources:
Abstract